Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01075321Phase 1/2Completed
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more
PrincipalinvestigatorStart date: 2011-01-10

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Craig Reeder, M.D.

Mayo Clinic

Very Similar
2 trials

Shared therapeutic areas:

Adult Nasal Type Extranodal NK/T-cell LymphomaLymphoma, Large-Cell, AnaplasticAngioimmunoblastic T-cell Lymphoma+16 more

Worked with same sponsors:

Mayo Clinic
Collaborated on 1 trial
Similarity Score194%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Moderately Similar
12 trials

Shared therapeutic areas:

Recurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+16 more
Similarity Score30%

Thomas E. Witzig, MD

Mayo Clinic

Related
12 trials

Shared therapeutic areas:

Lymphoma, Large-Cell, AnaplasticAngioimmunoblastic T-cell LymphomaHepatosplenic T-cell Lymphoma

Worked with same sponsors:

Mayo Clinic
Similarity Score5%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Recurrent Mantle Cell LymphomaWaldenstrom Macroglobulinemia
Similarity Score3%

Jun Zhu, MD

Peking University Cancer Hospital & Institute

Related
12 trials

Shared therapeutic areas:

Lymphoma, T-Cell, PeripheralLymphoma, Large-Cell, Anaplastic
Similarity Score3%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score2%

Eliot Epner, MD

Penn State Hershey Cancer Institute

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score2%

Maria Delioukina, MD

City of Hope National Medical Center, USA

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score2%

Peter Brown, MD

H:S Rigshospitalet, Department of Hematology, Denmark

Related
1 trials

Shared therapeutic areas:

Lymphoma, T-Cell, Peripheral
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01075321Phase 1/2PrincipalInvestigator

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more
Completed

All 1 trials loaded